🇺🇸 FDA
Pipeline program

KarXT, KarXT, KarXT, KarXT

CN012-0038

Phase 3 small_molecule active

Quick answer

KarXT, KarXT, KarXT, KarXT for Mania or Mania with Mixed Features in Bipolar-I Disorder is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).

Program details

Company
Bristol-Myers Squibb / Pfizer EEIG
Indication
Mania or Mania with Mixed Features in Bipolar-I Disorder
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials